These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 32031683

  • 1. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis.
    Kumar S, Verma AK, Rani R, Sharma A, Wang J, Shah SA, Behari J, Salazar Gonzalez R, Kohli R, Gandhi CR.
    Hepatology; 2020 Nov; 72(5):1586-1604. PubMed ID: 32031683
    [Abstract] [Full Text] [Related]

  • 2. Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.
    Gandhi CR, Chaillet JR, Nalesnik MA, Kumar S, Dangi A, Demetris AJ, Ferrell R, Wu T, Divanovic S, Stankeiwicz T, Shaffer B, Stolz DB, Harvey SA, Wang J, Starzl TE.
    Gastroenterology; 2015 Feb; 148(2):379-391.e4. PubMed ID: 25448926
    [Abstract] [Full Text] [Related]

  • 3. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G.
    J Transl Med; 2015 Jun 16; 13():193. PubMed ID: 26077675
    [Abstract] [Full Text] [Related]

  • 4. Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH.
    Bala S, Ganz M, Babuta M, Zhuang Y, Csak T, Calenda CD, Szabo G.
    Lab Invest; 2021 Dec 16; 101(12):1540-1549. PubMed ID: 34453120
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.
    Engin A.
    Adv Exp Med Biol; 2024 Dec 16; 1460():539-574. PubMed ID: 39287864
    [Abstract] [Full Text] [Related]

  • 6. CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease.
    Li G, Zhang J, Jiang Q, Liu B, Xu K.
    Life Sci; 2020 Aug 01; 254():117795. PubMed ID: 32417373
    [Abstract] [Full Text] [Related]

  • 7. Augmenter of liver regeneration: Mitochondrial function and steatohepatitis.
    Verma AK, Sharma A, Subramaniyam N, Gandhi CR.
    J Hepatol; 2022 Nov 01; 77(5):1410-1421. PubMed ID: 35777586
    [Abstract] [Full Text] [Related]

  • 8. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P, Aloman C, Ankireddy A, Khadra H, Ooka K, Gill RK, Saksena S, Dudeja PK, Alrefai WA.
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov 01; 313(5):G376-G385. PubMed ID: 28774869
    [Abstract] [Full Text] [Related]

  • 9. Protective role of cGAS in NASH is related to the maintenance of intestinal homeostasis.
    de Carvalho Ribeiro M, Cho Y, Mehta J, Wang X, Babuta M, Copeland C, Hussein H, Catalano D, Wang Y, Szabo G.
    Liver Int; 2023 Sep 01; 43(9):1937-1949. PubMed ID: 37222257
    [Abstract] [Full Text] [Related]

  • 10. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
    Saeed WK, Jun DW, Jang K, Ahn SB, Oh JH, Chae YJ, Lee JS, Kang HT.
    World J Gastroenterol; 2018 Dec 28; 24(48):5477-5490. PubMed ID: 30622377
    [Abstract] [Full Text] [Related]

  • 11. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G, An P, Vaid KA, Nasser I, Huang P, Tan L, Zhao S, Schuppan D, Popov YV.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G174-G188. PubMed ID: 31630534
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a murine nonalcoholic steatohepatitis model induced by high fat high calorie diet plus fructose and glucose in drinking water.
    Liu XJ, Duan NN, Liu C, Niu C, Liu XP, Wu J.
    Lab Invest; 2018 Sep 01; 98(9):1184-1199. PubMed ID: 29959418
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
    Schumacher JD, Kong B, Pan Y, Zhan L, Sun R, Aa J, Rizzolo D, Richardson JR, Chen A, Goedken M, Aleksunes LM, Laskin DL, Guo GL.
    Toxicol Appl Pharmacol; 2017 Sep 01; 330():1-8. PubMed ID: 28673684
    [Abstract] [Full Text] [Related]

  • 15. NLRP3 deficiency did not attenuate NASH development under high fat calorie diet plus high fructose and glucose in drinking water.
    Zhu LY, Liu C, Li ZR, Niu C, Wu J.
    Lab Invest; 2021 May 01; 101(5):588-599. PubMed ID: 33526807
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis.
    Kim MB, Lee Y, Bae M, Kang H, Pham TX, Hu S, Lee JY, Park YK.
    J Nutr Biochem; 2020 Nov 01; 85():108463. PubMed ID: 32891893
    [Abstract] [Full Text] [Related]

  • 18. Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma.
    Zheng M, Ai Z, Guo Y, Chen Y, Xie P, An W.
    Oncogene; 2023 Jan 01; 42(4):308-321. PubMed ID: 36434180
    [Abstract] [Full Text] [Related]

  • 19. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS, Lupke M, Ibrahim S, Buechler C, Lorenz J, Ruemmele P, Hofmann U, Melter M, Dayoub R.
    PLoS One; 2017 Jan 01; 12(9):e0184282. PubMed ID: 28877220
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.